Biotechnology Services Market Report 2026

Biotechnology Services Market Overview

• Biotechnology Services market size has reached to $178.54 billion in 2025 • Expected to grow to $314.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Effect Of Disease Prevalence And R&D On Biotechnology Services Market • Market Trend: Innovative Therapies In The Biotechnology Services Market • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Biotechnology Services Market?

Biotechnology services refer to the services that modify living microorganisms to provide biotechnology products on a contract or custom basis to medical, pharmaceutical, and scientific laboratories. They provide breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner, and more efficient industrial manufacturing processes. The main types of biotechnology services are prevention and disease control, public engagement activities, health education and research, food biotechnology services, donor recruitment, tissue collection, cell processing and isolation, and research and development. Food biotechnology services encompass a diverse variety of technologies used in crops, livestock, forestry, fisheries and aquaculture, and agro-industry. They are used for a variety of purposes, including genetic improvement of plants and animals to increase yields or efficiency, characterization and conservation of genetic resources for food and agriculture, plant and animal disease diagnosis, vaccine development, and fermented food production. The various applications include pharmaceutical, biotechnological, academic, clinical trial, and healthcare sectors and are used by Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), and Contract Research and Manufacturing Services (CRAMS).

What Is The Biotechnology Services Market Growth Forecast?

The biotechnology services market size is expected to see rapid growth in the next few years. It will grow to $314.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing adoption of precision medicine, rising investments in genomics research, expansion of cell and gene therapy pipelines, growing demand for scalable biotechnology services, increasing integration of ai in life science research. Major trends in the forecast period include increasing outsourcing of drug discovery services, rising demand for cell processing and isolation services, growing adoption of contract research models, expansion of personalized medicine support services, enhanced focus on translational research capabilities.

Global Biotechnology Services Market Segmentation

1) By Service: Research & Development Services, Cell & Gene Processing Services, Preclinical & Clinical Research Services, Analytical & Testing Services 2) By Service Delivery Model: Contract Research Organization (CRO) Services, Contract Development and Manufacturing Organization (CDMO) Services, Contract Research and Manufacturing Services (CRAMS) 3) By Area of Application: Pharmaceutical, Biotechnology, Clinical Trials, Research & Development Services Subsegments: 1) By Research & Development Services: Drug Discovery & Target Identification, Assay Development & Screening Services, Biomarker Discovery & Validation 2) By Cell & Gene Processing Services: Stem Cell Processing & Expansion, Immune Cell Isolation & Engineering, Gene Editing & Vector Development 3) By Preclinical & Clinical Research Services: In-Vitro & In-Vivo Preclinical Studies, Clinical Trial Design & Management, Bioanalytical & Pharmacokinetic Studies 4) By Analytical & Testing Services: Genomic & Proteomic Testing, Bioanalytical Testing, Quality Control & Validation Testing

What Is The Driver Of The Biotechnology Services Market?

The increasing pervasiveness of conditions like hepatitis B, diabetes, and cancer is driving biotechnology research. Biotechnology uses research tools from biology and chemistry to study the genetic material of bacteria and viruses to check the disease-producing agents. Oncology research is most prominent among biopharma companies. Stem cell treatment using a monoclonal antibody for therapy and genome sequencing is progressing in medical applications. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Furthermore, for instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising pervasiveness of diseases and huge expenses on R&D are predicted to contribute to the growth of the biotechnology services industry.

Key Players In The Global Biotechnology Services Market

Major companies operating in the biotechnology services market include Parexel International Corporation, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, IQVIA, ICON plc, Charles River Laboratories, Syneos Health, Sartorius AG, Precision for Medicine Inc., Novartis, Eppendorf Asia Pacific Sdn. Bhd., Emmessar Biotech & Nutrition LTD, Vcanbio Cell & Gene Engineering Corp., LTD, Ke Rui Gene, Absea Biotechnology LTD, CStone Pharm-B, Daiichi Sankyo, bitBiome, Taisho Pharmaceutical, AGC Biologics, Hamamatsu Pharma Research, Artios Pharma, AstraZeneca, Bio Products Laboratory (BPL), Cambridge Bioscience, Shire Pharmaceuticals LTD, BTG LTD, eXmoor Pharma, 4D Pharma PLC, Touchlight Genetics, Ophidia Medical Technologies, ATAI Life Sciences, Phaseform, Evotec, Sanity Group, Primmbiotech Vaccitech, Biolat, Asla-Biotech, Genera, Anima Lab, Silvanols, OU TBD-Biodiscovery, Qvalitas Arstikeskus AS, Concise Systems OU, GPE Globalpharma OU, Belarusian National Biotechnology Corporation, Innothera, Olainfarm, Pharmaidea, Amgen Inc., Gilead Sciences, Celgene Corporation, Biogen Inc., Vertex Pharmaceuticals, Illumina, Inc., Regeneron Pharmaceuticals Inc., Alexion Pharmaceuticals, Hemostemix Inc., Resverlogix Corporation, Zenith Epigenetics Corp., Bayer, AMEGA Biotech, Pierre Fabre, Pfizer, Quantificare, Apsen Farmaceutica, BioMarin Pharmaceutical, DK Diagnostics, Biosonda Biotechnology, Laboratorios Legrand, Biomerics, Julphar Pharmaceuticals, Medpharma, Pharmax, Neopharma, City Breeze Technical Services, CinnaGen, BioSun Pharmed, AryoGen Pharmed, 4Clinics, 54gene, Amoun, Aspen Pharmacare, BBI Solutions, BioTech Africa, ClinArt MENA, Crux Pharmaceuticals, Genesis Pharmaceuticals, Massive Genomics, Mayne Pharma, Sanofi Genzyme, Teleflex Medical, The Micron Group

Global Biotechnology Services Market Trends and Insights

Major companies operating in the biotechnology services market are focusing on developing innovative therapies such as biomarker algorithms for first-line treatment of patients with non-small cell lung cancer (NSCLC). A biomarker algorithm is a mathematical or computational model that combines data from multiple biomarkers or biological indicators to provide a more comprehensive and accurate assessment of a particular biological or medical condition. For instance, in April 2023, Strata Oncology Inc., a US-based precision oncology company, announced the launch of Strata Select, a first-of-its-kind molecular profiling test for patients with advanced cancer. Strata Select is the first immunotherapy biomarker algorithm to be covered by Medicare across solid tumors meeting specified coverage criteria. The launch empowers oncologists to make better-informed treatment decisions and enhance patient outcomes.

What Are Latest Mergers And Acquisitions In The Biotechnology Services Market?

In December 2023, Eli Lilly and Company, a US-based pharmaceutical company, acquired POINT Biopharma Global Inc. for an undisclosed amount. This strategic deal is intended to strengthen Lilly's oncology expertise, especially in the field of advanced radioligand therapies aimed at treating different types of cancer. POINT Biopharma Global Inc. is a US-based biotechnology firm known for its innovative approaches to the treatment of cancer.

Regional Insights

Asia-Pacific was the largest region in the biotechnology services market in 2025. North America was the second largest region in the global biotechnology services market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biotechnology Services Market?

The biotechnology services market consists of revenue earned by entities that engage in conducting research and experimental development in biotechnology. Numerous global issues are helped by biotechnology, including infectious diseases, ageing societies, food security, energy security, and climate change, to name a few. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biotechnology Services Market Report 2026?

The biotechnology services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.